Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage

Background: Neuroprotection studies are generally unable to demonstrate efficacy in humans. Our specific hypothesis is that multiple pathophysiologic pathways, of variable importance, contribute to ischemic brain damage. As a corollary to this, we discuss the broad hypothesis that a multifaceted app...

Full description

Bibliographic Details
Main Authors: William A. Kofke, Yue Ren, John G. Augoustides, Hongzhe Li, Katherine Nathanson, Robert Siman, Qing Cheng Meng, Weiming Bu, Sukanya Yandrawatthana, Guy Kositratna, Cecilia Kim, Joseph E. Bavaria
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2018.00497/full
_version_ 1828907739923873792
author William A. Kofke
Yue Ren
John G. Augoustides
Hongzhe Li
Katherine Nathanson
Robert Siman
Qing Cheng Meng
Weiming Bu
Sukanya Yandrawatthana
Guy Kositratna
Cecilia Kim
Joseph E. Bavaria
author_facet William A. Kofke
Yue Ren
John G. Augoustides
Hongzhe Li
Katherine Nathanson
Robert Siman
Qing Cheng Meng
Weiming Bu
Sukanya Yandrawatthana
Guy Kositratna
Cecilia Kim
Joseph E. Bavaria
author_sort William A. Kofke
collection DOAJ
description Background: Neuroprotection studies are generally unable to demonstrate efficacy in humans. Our specific hypothesis is that multiple pathophysiologic pathways, of variable importance, contribute to ischemic brain damage. As a corollary to this, we discuss the broad hypothesis that a multifaceted approach will improve the probability of efficacious neuroprotection. But to properly test this hypothesis the nature and importance of the multiple contributing pathways needs elucidation. Our aim is to demonstrate, using functional genomics, in human cardiac surgery procedures associated with cerebral ischemia, that the pathogenesis of perioperative human ischemic brain damage involves the function of multiple variably weighted proteins involving several pathways. We then use these data and literature to develop a proposal for rational design of human neuroprotection protocols.Methods: Ninety-four patients undergoing deep hypothermic circulatory arrest (DHCA) and/or aortic valve replacement surgery had brain damage biomarkers, S100β and neurofilament H (NFH), assessed at baseline, 1 and 24 h post-cardiopulmonary bypass (CPB) with analysis for association with 92 single nucleotide polymorphisms (SNPs) (selected by co-author WAK) related to important proteins involved in pathogenesis of cerebral ischemia.Results: At the nominal significance level of 0.05, changes in S100β and in NFH at 1 and 24 h post-CPB were associated with multiple SNPs involving several prospectively determined pathophysiologic pathways, but were not individually significant after multiple comparison adjustments. Variable weights for the several evaluated SNPs are apparent on regression analysis and, notably, are dissimilar related to the two biomarkers and over time post CPB. Based on our step-wise regression model, at 1 h post-CPB, SOD2, SUMO4, and GP6 are related to relative change of NFH while TNF, CAPN10, NPPB, and SERPINE1 are related to the relative change of S100B. At 24 h post-CPB, ADRA2A, SELE, and BAX are related to the relative change of NFH while SLC4A7, HSPA1B, and FGA are related to S100B.Conclusions: In support of the proposed hypothesis, association SNP data suggest function of specific disparate proteins, as reflected by genetic variation, may be more important than others with variation at different post-insult times after human brain ischemia. Such information may support rational design of post-insult time-sensitive multifaceted neuroprotective therapies.
first_indexed 2024-12-13T17:58:12Z
format Article
id doaj.art-0e3905e2ab1c414daa4839295883e157
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-13T17:58:12Z
publishDate 2018-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-0e3905e2ab1c414daa4839295883e1572022-12-21T23:36:18ZengFrontiers Media S.A.Frontiers in Neurology1664-22952018-06-01910.3389/fneur.2018.00497325022Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain DamageWilliam A. Kofke0Yue Ren1John G. Augoustides2Hongzhe Li3Katherine Nathanson4Robert Siman5Qing Cheng Meng6Weiming Bu7Sukanya Yandrawatthana8Guy Kositratna9Cecilia Kim10Joseph E. Bavaria11Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Medicine, Division of Translational Medicine and Human Genetics Abramson Cancer Center Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United StatesThe Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Surgery, University of Pennsylvania, Philadelphia, PA, United StatesBackground: Neuroprotection studies are generally unable to demonstrate efficacy in humans. Our specific hypothesis is that multiple pathophysiologic pathways, of variable importance, contribute to ischemic brain damage. As a corollary to this, we discuss the broad hypothesis that a multifaceted approach will improve the probability of efficacious neuroprotection. But to properly test this hypothesis the nature and importance of the multiple contributing pathways needs elucidation. Our aim is to demonstrate, using functional genomics, in human cardiac surgery procedures associated with cerebral ischemia, that the pathogenesis of perioperative human ischemic brain damage involves the function of multiple variably weighted proteins involving several pathways. We then use these data and literature to develop a proposal for rational design of human neuroprotection protocols.Methods: Ninety-four patients undergoing deep hypothermic circulatory arrest (DHCA) and/or aortic valve replacement surgery had brain damage biomarkers, S100β and neurofilament H (NFH), assessed at baseline, 1 and 24 h post-cardiopulmonary bypass (CPB) with analysis for association with 92 single nucleotide polymorphisms (SNPs) (selected by co-author WAK) related to important proteins involved in pathogenesis of cerebral ischemia.Results: At the nominal significance level of 0.05, changes in S100β and in NFH at 1 and 24 h post-CPB were associated with multiple SNPs involving several prospectively determined pathophysiologic pathways, but were not individually significant after multiple comparison adjustments. Variable weights for the several evaluated SNPs are apparent on regression analysis and, notably, are dissimilar related to the two biomarkers and over time post CPB. Based on our step-wise regression model, at 1 h post-CPB, SOD2, SUMO4, and GP6 are related to relative change of NFH while TNF, CAPN10, NPPB, and SERPINE1 are related to the relative change of S100B. At 24 h post-CPB, ADRA2A, SELE, and BAX are related to the relative change of NFH while SLC4A7, HSPA1B, and FGA are related to S100B.Conclusions: In support of the proposed hypothesis, association SNP data suggest function of specific disparate proteins, as reflected by genetic variation, may be more important than others with variation at different post-insult times after human brain ischemia. Such information may support rational design of post-insult time-sensitive multifaceted neuroprotective therapies.https://www.frontiersin.org/article/10.3389/fneur.2018.00497/fullneuroprotectionfunctional genomicscerebral ischemiacardiac surgerycardiopulmonary bypassbiomarkers
spellingShingle William A. Kofke
Yue Ren
John G. Augoustides
Hongzhe Li
Katherine Nathanson
Robert Siman
Qing Cheng Meng
Weiming Bu
Sukanya Yandrawatthana
Guy Kositratna
Cecilia Kim
Joseph E. Bavaria
Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage
Frontiers in Neurology
neuroprotection
functional genomics
cerebral ischemia
cardiac surgery
cardiopulmonary bypass
biomarkers
title Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage
title_full Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage
title_fullStr Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage
title_full_unstemmed Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage
title_short Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage
title_sort reframing the biological basis of neuroprotection using functional genomics differentially weighted time dependent multifactor pathogenesis of human ischemic brain damage
topic neuroprotection
functional genomics
cerebral ischemia
cardiac surgery
cardiopulmonary bypass
biomarkers
url https://www.frontiersin.org/article/10.3389/fneur.2018.00497/full
work_keys_str_mv AT williamakofke reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT yueren reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT johngaugoustides reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT hongzheli reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT katherinenathanson reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT robertsiman reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT qingchengmeng reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT weimingbu reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT sukanyayandrawatthana reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT guykositratna reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT ceciliakim reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage
AT josephebavaria reframingthebiologicalbasisofneuroprotectionusingfunctionalgenomicsdifferentiallyweightedtimedependentmultifactorpathogenesisofhumanischemicbraindamage